NFKB1 and aneurysmal bone cyst: ABC-DLBCL relies heavily on NF-κB signaling and shows chronic BCR activation that is needed for survival, which translates into differential sensitivity to drugs targeting these pathways between ABC and GCB DLBCL cases [21, 22].